420 CHAPTER 5 14. Crowley EK, Sallevelt BTGM, Huibers CJA, Murphy KD, Spruit M, Shen Z, et al. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): A structured medication review with support of a computerised decision support system. BMC Health Serv Res 2020;20:1–12. https:// doi.org/10.1186/s12913-020-5056-3. 15. Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M’Rabet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): A cluster randomised controlled trial. BMJ Open 2019;9:1–9. https://doi.org/10.1136/bmjopen-2018-026769. 16. Blum MR, Sallevelt BTGM, Spinewine A, Mahony DO, Feller M, Baumgartner C, et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ 2021;374:n1585. https:// doi.org/10.1136/bmj.n1585. 17. Baumgartner AD, Clark CM, LaValley SA, Monte S V., Wahler RG, Singh R. Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation? J Clin Pharm Ther 2020;45:453–61. https://doi.org/10.1111/jcpt.13103. 18. Davies EA, O’Mahony MS. Adverse drug reactions in special populations - The elderly. Br J Clin Pharmacol 2015. https://doi.org/10.1111/bcp.12596. 19. Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 2021;12:463–73. https://doi. org/10.1007/s41999-021-00481-9. 20. Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 2017. https://doi.org/10.1007/s00228017-2225-3. 21. Alhawassi TM, Krass I, Bajorek B, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 2014. https://doi.org/10.2147/CIA.S71178. 22. Nair NP, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions - The need for a prediction tool. Clin Interv Aging 2016;11:497–505. https://doi.org/10.2147/CIA.S99097. 23. Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/ START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs and Aging 2021. https://doi.org/10.1007/s40266-021-00904-z. 24. Grol R, Grimshaw J. From best evidence to best practice: Effective implementation of change in patients’ care. Lancet 2003. https://doi.org/10.1016/S0140-6736(03)14546-1. 25. Michie S. Changing clinical behaviour by making guidelines specific. BMJ 2004. https:// doi.org/10.1136/bmj.328.7435.343. 26. Sallevelt BTGM, Huibers CJA, Knol W, Puijenbroek E Van, Egberts T, Wilting I. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: A quality appraisal study. BMJ Open 2020;10:1–8. https://doi.org/10.1136/ bmjopen-2019-033721. 27. Van Uden RCAE, Houtenbos I, Griffioen-Keijzer A, Odekerken DAM, Van Den Bemt PMLA, Becker ML. Guidelines for mono, double and triple antithrombotic therapy. Postgrad Med J 2021;97:730–7. https://doi.org/10.1136/postgradmedj-2020-138938. 28. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015;44:213–8. https://doi.org/10.1093/ageing/afu145.
RkJQdWJsaXNoZXIy MTk4NDMw